Menu
Back to User profile » Dr Xiangyi Kong
Papers published by Dr Xiangyi Kong:
Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
Chen L, Kong X, Wang Z, Wang X, Fang Y, Wang J
Cancer Management and Research 2020, 12:1543-1567
Published Date: 3 March 2020
The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer
Chen L, Kong X, Yan C, Fang Y, Wang J
OncoTargets and Therapy 2020, 13:1397-1412
Published Date: 14 February 2020
Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas
Kong X, Zhang K, Wang X, Yang X, Li Y, Zhai J, Xing Z, Qi Y, Gao R, Feng X, Wang J, Fang Y
Cancer Management and Research 2019, 11:5971-5982
Published Date: 2 July 2019
Effects of anesthetic technique and surgery on myeloid-derived suppressor cells and prognosis in women who underwent breast cancer surgery: a prospective study
Yan T, Zhang GH, Cheng YZ, Wu LX, Liu XY, Sun YL, Zheng H, Sun L
Cancer Management and Research 2019, 11:5513-5522
Published Date: 18 June 2019
Microsurgical treatment of parafalcine meningiomas: a retrospective study of 126 cases
Kong X, Gong S, Lee IT, Yang Y
OncoTargets and Therapy 2018, 11:5279-5285
Published Date: 30 August 2018
MicroRNA-200b expression level is negatively associated with pathological grading in human gliomas
Kong X, Gong S, Yan T, Yang Y
Cancer Management and Research 2018, 10:2825-2834
Published Date: 24 August 2018
An uncommon granulocytic sarcoma of the breast: a case report and literature review
Zhai J, Kong X, Yang X, Gao J, Xuan L, Wang X, Wang J, Fang Y
OncoTargets and Therapy 2018, 11:3685-3690
Published Date: 25 June 2018
Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?
Kong X, Kong Y
OncoTargets and Therapy 2017, 10:1335-1344
Published Date: 1 March 2017